Overall, 55.8% of infants were protected by either maternal RSV vaccination, nirsevimab, or both; 14.2% of infants were ...

The global health organization says the lack of rapid diagnostic tests results in undertreatment and overtreatment of ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Though Rwanda ’ s outbreak marks the first Marburg event of 2024, it comes closely on the heels of outbreaks in 2023 that ...

An estimated 51% of long-COVID patients satisfied ME/CFS diagnostic criteria. The most common symptoms were fatigue, sleep ...

The US Department of Health and Human Services (HHS) last week announced funding for a project that will use artificial ...